Literature DB >> 30288516

A biodegradable fluorescent nanohybrid for photo-driven tumor diagnosis and tumor growth inhibition.

Rajendra Prasad1, Deepak S Chauhan, Amit S Yadav, Janhavi Devrukhkar, Barkha Singh, Mahadeo Gorain, Mayur Temgire, Jayesh Bellare, Gopal C Kundu, Rohit Srivastava.   

Abstract

Specific targeting and phototriggered therapy in mouse model have recently emerged as the starting point of cancer theragnosis. Herein, we report a bioresponsive and degradable nanohybrid, a liposomal nanohybrid decorated with red emissive carbon dots, for localized tumor imaging and light-mediated tumor growth inhibition. Unsaturated carbon dots (C-dots) anchored to liposomes convert near-infrared (NIR) light into heat and also produce reactive oxygen species (ROS), demonstrating the capability of phototriggered cancer cell death and tumor regression. The photothermal and oxidative damage of breast tumor by the nonmetallic nanohybrid has also been demonstrated. Designed nanoparticles show excellent aqueous dispersibility, biocompatibility, light irradiated enhanced cellular uptake, release of reactive oxygen species, prolonged and specific tumor binding ability and good photothermal response (62 °C in 5 minutes). Safe and localized irradiation of 808 nm light demonstrates significant tumor growth inhibition and bioresponsive degradation of the fluorescent nanohybrid without affecting the surrounding healthy tissues.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30288516     DOI: 10.1039/c8nr05164j

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  9 in total

1.  Clearable Nanoparticles for Cancer Photothermal Therapy.

Authors:  Jun Zhao; Xin Long; Min Zhou
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Stealth Liposomal Chemotherapeutic Agent for Triple Negative Breast Cancer with Improved Pharmacokinetics.

Authors:  Nagavendra Kommineni; David Paul; Raju Saka; Wahid Khan; Satheeshkumar Nanjappan
Journal:  Nanotheranostics       Date:  2022-08-21

3.  Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer.

Authors:  Sneha Mahalunkar; Amit Singh Yadav; Mahadeo Gorain; Vinay Pawar; Ranveig Braathen; Siegfried Weiss; Bjarne Bogen; Suresh W Gosavi; Gopal C Kundu
Journal:  Int J Nanomedicine       Date:  2019-10-15

Review 4.  The Potential Application of Magnetic Nanoparticles for Liver Fibrosis Theranostics.

Authors:  Aziz Eftekhari; Allahveirdy Arjmand; Ayyub Asheghvatan; Helena Švajdlenková; Ondrej Šauša; Huseyn Abiyev; Elham Ahmadian; Oleh Smutok; Rovshan Khalilov; Taras Kavetskyy; Magali Cucchiarini
Journal:  Front Chem       Date:  2021-05-14       Impact factor: 5.221

5.  Novel Carbon Dots Derived from Puerariae lobatae Radix and Their Anti-Gout Effects.

Authors:  Xiaoke Wang; Yue Zhang; Meiling Zhang; Hui Kong; Suna Wang; Jinjun Cheng; Huihua Qu; Yan Zhao
Journal:  Molecules       Date:  2019-11-16       Impact factor: 4.411

6.  Liposomal nanotheranostics for multimode targeted in vivo bioimaging and near-infrared light mediated cancer therapy.

Authors:  Rajendra Prasad; Nishant K Jain; Amit S Yadav; Deepak S Chauhan; Janhavi Devrukhkar; Mukesh K Kumawat; Shweta Shinde; Mahadeo Gorain; Avnesh S Thakor; Gopal C Kundu; João Conde; Rohit Srivastava
Journal:  Commun Biol       Date:  2020-06-05

7.  The combination of MnO2@Lipo-coated gefitinib and bevacizumab inhibits the development of non-small cell lung cancer.

Authors:  Jisong Zhang; Li Xu; Huihui Hu; Enguo Chen
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

Review 8.  Antitumor Applications of Photothermal Agents and Photothermal Synergistic Therapies.

Authors:  Chaowei Li; Yue Cheng; Dawei Li; Qi An; Wei Zhang; Yu Zhang; Yijun Fu
Journal:  Int J Mol Sci       Date:  2022-07-18       Impact factor: 6.208

Review 9.  Design and Application of Near-Infrared Nanomaterial-Liposome Hybrid Nanocarriers for Cancer Photothermal Therapy.

Authors:  Pan Liang; Linshen Mao; Yanli Dong; Zhenwen Zhao; Qin Sun; Maryam Mazhar; Yining Ma; Sijin Yang; Wei Ren
Journal:  Pharmaceutics       Date:  2021-12-03       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.